Eurosurveillance最新文献_第5页

First case of mpox with monkeypox virus clade Ib outside Africa in a returning traveller, Sweden, August 2024: public health measures.

IF 9.9 2区医学

Eurosurveillance Pub Date : 2024-11-01 DOI: 10.2807/1560-7917.ES.2024.29.48.2400740

Carl-Johan Treutiger, Finn Filén, Moa Rehn, Johan Aarum, Andreas Jacks, Magnus Gisslén, Erik Sturegård, Maria Lind Karlberg, Oskar Karlsson Lindsjö, Klara Sondén

引用次数: 0

Trends in new HIV diagnoses and factors contributing to late diagnosis among migrant populations in EU/EEA countries, 2014 to 2023.

IF 9.9 2区医学

Eurosurveillance Pub Date : 2024-11-01 DOI: 10.2807/1560-7917.ES.2024.29.48.2400759

Juliana Reyes-Urueña, Giorgia Stoppa, Federica Pizzolato, Marieke J van der Werf, Charlotte Deogan, Vítor Cabral-Veríssimo, Helena Cortes-Martins, Jessika Deblonde, Asuncion Diaz, Victoria Hernando, Erna Milunka-Kojic, Joël Mossong, Kate O'Donnell, Eline Op de Coul, Chrysa Tsiara, Lilian van Leest, Dominique Van Beckhoven, Maria Wessman, Robert Whittaker

引用次数: 0

Locally acquired malaria: a retrospective analysis of long-term surveillance data, European France, 1995 to 2022. 局部获得性疟疾：1995 年至 2022 年欧洲法国长期监测数据的回顾性分析。

IF 9.9 2区医学

Eurosurveillance Pub Date : 2024-10-01 DOI: 10.2807/1560-7917.ES.2024.29.41.2400133

Hugues Delamare, Arnaud Tarantola, Marc Thellier, Clémentine Calba, Olivier Gaget, Paul-Henri Consigny, Frederic Simard, Sylvie Manguin, Elise Brottet, Marie-Claire Paty, Sandrine Houze, Henriette De Valk, Harold Noël

{"title":"Locally acquired malaria: a retrospective analysis of long-term surveillance data, European France, 1995 to 2022.","authors":"Hugues Delamare, Arnaud Tarantola, Marc Thellier, Clémentine Calba, Olivier Gaget, Paul-Henri Consigny, Frederic Simard, Sylvie Manguin, Elise Brottet, Marie-Claire Paty, Sandrine Houze, Henriette De Valk, Harold Noël","doi":"10.2807/1560-7917.ES.2024.29.41.2400133","DOIUrl":"10.2807/1560-7917.ES.2024.29.41.2400133","url":null,"abstract":"BackgroundIn European France, the bulk of malaria cases are travel-related, and only locally acquired cases are notifiable to assess any risk of re-emergence.AimsWe aimed to contribute to assessing the health impact of locally acquired malaria and the potential of malaria re-emergence in European France by documenting modes of transmission of locally acquired malaria, the Plasmodium species involved and their incidence trends.MethodsWe retrospectively analysed surveillance and case investigation data on locally acquired malaria from 1995 to 2022. We classified cases by most likely mode of transmission using a classification derived from the European Centre for Disease Prevention and Control. A descriptive analysis was conducted to identify spatial and temporal patterns of cases.ResultsFrom 1995 to 2022, European France reported 117 locally acquired malaria cases, mostly due to Plasmodium falciparum (88%) and reported in Île-de-France (54%), Paris Region. Cases were classified as Odyssean malaria (n = 51), induced malaria (n = 36), cryptic malaria (n = 27) and introduced malaria (n = 3). Among the 117 patients, 102 (93%) were hospitalised, 24 (22%) had severe malaria and seven (7%) died.ConclusionLocally acquired malaria remains infrequent in European France, with four reported cases per year since 1995. However, with the recent increasing trend in Odyssean malaria and climate change, the risk of re-emergence in non-endemic countries should be monitored, particularly in areas with autochthonous competent vectors. The vital risk of delayed diagnosis should make physicians consider locally acquired malaria in all patients with unexplained fever, especially when thrombocytopenia is present, even without travel history.","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"29 41","pages":""},"PeriodicalIF":9.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11484917/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142399846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Increasing trends in hepatitis E hospitalisations in Spain, 1997 to 2019. 1997 年至 2019 年西班牙戊型肝炎住院人数的增长趋势。

IF 9.9 2区医学

Eurosurveillance Pub Date : 2024-10-01 DOI: 10.2807/1560-7917.ES.2024.29.43.2400118

María Guerrero-Vadillo, Marina Peñuelas, Rocío Carmona, Inmaculada León-Gómez, Carmen Varela

{"title":"Increasing trends in hepatitis E hospitalisations in Spain, 1997 to 2019.","authors":"María Guerrero-Vadillo, Marina Peñuelas, Rocío Carmona, Inmaculada León-Gómez, Carmen Varela","doi":"10.2807/1560-7917.ES.2024.29.43.2400118","DOIUrl":"10.2807/1560-7917.ES.2024.29.43.2400118","url":null,"abstract":"BackgroundHepatitis E, a viral hepatitis caused mainly by the ingestion of raw or undercooked food, is not a notifiable disease in Spain.AimTo analyse the temporal trends, epidemiological characteristics and factors associated with severe disease from hepatitis E hospitalisations in Spain from 1997 to 2019.MethodsHospitalisation records were obtained from the Spanish National Hospital Discharge Database. Temporal trends and seasonality were analysed by Poisson regression in years 1997-2015 and 2016-19, given changes in hospital discharge databases. Multivariate logistic regression was used to identify factors associated with severe disease.ResultsHepatitis E hospitalisation incidence increased from 0.22 cases per 1,000,000 inhabitants in 1997 to a maximum of 2.95 in 2018. Seasonality was observed during 2016-19 period, with more cases in the second and third quarters of the year. The incidence was higher in men vs women, and in the population aged over 40 years. Factors independently associated with death were age ≥ 50 years (adjusted odds ratio (aOR): 2.43), chronic liver disease (aOR: 4.29), HIV infection (aOR: 3.00) and hepatitis B/C (aOR: 2.11).ConclusionsHepatitis E hospitalisations have increased in Spain in recent years, being more severe in cases with older age, chronic hepatic diseases and HIV infection. A greater incidence in men over 40 years and a possible seasonality were observed. Further studies are needed to assess the seasonality, geographical distribution and impact of the disease to guide public health actions for prevention and control.","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"29 43","pages":""},"PeriodicalIF":9.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11513759/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142497705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24. 2023年秋季COVID-19疫苗在医院医护人员中的有效性：VEBIS医护人员疫苗有效性队列研究的结果，七个欧洲国家，2023/24季。

IF 9.9 2区医学

Eurosurveillance Pub Date : 2024-10-01 DOI: 10.2807/1560-7917.ES.2024.29.44.2400680

Camelia Savulescu, Albert Prats-Uribe, Kim Brolin, Anneli Uusküla, Colm Bergin, Catherine Fleming, Rita Murri, Viesturs Zvirbulis, Dace Zavadska, Vania Gaio, Corneliu P Popescu, Raluca Hrisca, Maria Cisneros, Miriam Latorre-Millán, Liis Lohur, Jonathan McGrath, Lauren Ferguson, Katleen De Gaetano Donati, Ilze Abolina, Dagne Gravele, Ausenda Machado, Simin-Aysel Florescu, Mihaela Lazar, Pilar Subirats, Laura Clusa Cuesta, Jacklyn Sui, Claire Kenny, Rosaria Santangelo, Dainis Krievins, Elza Anna Barzdina, Camila Valadas Henriques, Alma Gabriela Kosa, Saftica-Mariana Pohrib, Carmen Muñoz-Almagro, Ana Milagro, Sabrina Bacci, Anthony Nardone

{"title":"Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24.","authors":"Camelia Savulescu, Albert Prats-Uribe, Kim Brolin, Anneli Uusküla, Colm Bergin, Catherine Fleming, Rita Murri, Viesturs Zvirbulis, Dace Zavadska, Vania Gaio, Corneliu P Popescu, Raluca Hrisca, Maria Cisneros, Miriam Latorre-Millán, Liis Lohur, Jonathan McGrath, Lauren Ferguson, Katleen De Gaetano Donati, Ilze Abolina, Dagne Gravele, Ausenda Machado, Simin-Aysel Florescu, Mihaela Lazar, Pilar Subirats, Laura Clusa Cuesta, Jacklyn Sui, Claire Kenny, Rosaria Santangelo, Dainis Krievins, Elza Anna Barzdina, Camila Valadas Henriques, Alma Gabriela Kosa, Saftica-Mariana Pohrib, Carmen Muñoz-Almagro, Ana Milagro, Sabrina Bacci, Anthony Nardone","doi":"10.2807/1560-7917.ES.2024.29.44.2400680","DOIUrl":"10.2807/1560-7917.ES.2024.29.44.2400680","url":null,"abstract":"COVID-19 vaccination recommendations include healthcare workers (HCWs). We measured COVID-19 vaccine effectiveness (CVE) of the autumn 2023 dose against laboratory-confirmed SARS-CoV-2 infection in a prospective cohort study of 1,305 HCWs from 13 European hospitals. Overall CVE was 22% (95% CI: -17 to 48), 49% (95% CI: -8 to 76) before and -11% (95% CI: -84 to 34) after the start of BA.2.86/JN.1 predominant circulation. Autumn 2023 COVID-19 vaccination led to a moderate-to-low reduction in SARS-CoV-2 infection incidence in HCWs. Monitoring of CVE is crucial for COVID-19 prevention.","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"29 44","pages":""},"PeriodicalIF":9.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11528902/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142557484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Attribution of invasive group A streptococcal infections (iGAS) to predisposing viral infections, the Netherlands, 2010 to 2023. 2010 年至 2023 年荷兰侵袭性 A 组链球菌感染 (iGAS) 与易感病毒感染的关系。

IF 9.9 2区医学

Eurosurveillance Pub Date : 2024-10-01 DOI: 10.2807/1560-7917.ES.2024.29.40.2300739

Brechje de Gier, Jan van de Kassteele, Liselotte van Asten, Annelot F Schoffelen, Mariette Hooiveld, Margreet Jm Te Wierik, Nina M van Sorge, Hester E de Melker

{"title":"Attribution of invasive group A streptococcal infections (iGAS) to predisposing viral infections, the Netherlands, 2010 to 2023.","authors":"Brechje de Gier, Jan van de Kassteele, Liselotte van Asten, Annelot F Schoffelen, Mariette Hooiveld, Margreet Jm Te Wierik, Nina M van Sorge, Hester E de Melker","doi":"10.2807/1560-7917.ES.2024.29.40.2300739","DOIUrl":"10.2807/1560-7917.ES.2024.29.40.2300739","url":null,"abstract":"BackgroundAfter most COVID-19 pandemic control measures were lifted in 2022, many infectious diseases re-emerged. An increase in invasive group A streptococcal (iGAS) infections among adults and young children was reported by several countries. Viral infections including influenza and varicella, known risk factors for iGAS infection, also increased.AimTo estimate the proportion of GAS skin and soft tissue infections (SSTI) and pneumonia/sepsis in children (≤ 5 years) attributable to varicella, and the proportion of GAS pneumonia/sepsis in children and adults attributable to potentially predisposing respiratory viruses influenza A and B, RSV, hMPV and SARS-CoV-2 in the Netherlands.MethodsWe performed time series regression using weekly data on respiratory viruses, varicella and non-invasive GAS infections and GAS isolates cultured from blood, lower airways, skin, pus and wounds, from January 2010 to March 2023.ResultsIn 2010-19, 50% (95% CI: 36-64) of GAS SSTI in children were attributable to varicella. Between January 2022 and March 2023, 34% (95% CI: 24-43) of GAS SSTI cases were attributable to varicella. Of iGAS pneumonia/sepsis between January 2022 and March 2023, 34% (95% CI: 20-49) and 25% (95% CI: 18-32) was attributable to respiratory virus infections in children and adults, respectively, with the largest contributor (17%) being influenza A.ConclusionsPredisposing viral infections likely contributed to, but cannot fully explain, the observed iGAS increase among children and adults in 2022-23 in the Netherlands. Public health measures to control viral infections, such as vaccination against varicella or influenza, might reduce the iGAS disease burden.","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"29 40","pages":""},"PeriodicalIF":9.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11451131/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142371392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Enhanced laboratory surveillance of respiratory infection disclosed the rapid rise of enterovirus D68 cases, northern Italy, August to September 2024. 2024 年 8 月至 9 月，意大利北部地区呼吸道感染实验室监测的加强披露了肠道病毒 D68 病例的快速上升。

IF 9.9 2区医学

Eurosurveillance Pub Date : 2024-10-01 DOI: 10.2807/1560-7917.ES.2024.29.41.2400645

Elena Pariani, Antonio Piralla, Laura Pellegrinelli, Federica Giardina, Vincenzo Navobi Porrello, Greta Romano, Cristina Galli, Laura Sandri, Guglielmo Ferrari, Sandro Binda, Luigi Vezzosi, Gabriele Del Castillo, Sabrina Buoro, Danilo Cereda, Fausto Baldanti

引用次数: 0

Letter to the Editor: First detection of a Mycobacterium tuberculosis XDR clinical isolate harbouring an RpoB I491F mutation in a Ukrainian patient treated in Germany, October 2023. 致编辑的信：2023 年 10 月，在德国接受治疗的一名乌克兰患者中首次检测到携带 RpoB I491F 突变的 XDR 型结核分枝杆菌临床分离株。

IF 9.9 2区医学

Eurosurveillance Pub Date : 2024-10-01 DOI: 10.2807/1560-7917.ES.2024.29.42.2400665

Florian Heger, Alexander Indra

引用次数: 0

Integrating indicator-based and event-based surveillance data for risk mapping of West Nile virus, Europe, 2006 to 2021. 整合基于指标和基于事件的监测数据，绘制西尼罗河病毒风险图，欧洲，2006 年至 2021 年。

IF 9.9 2区医学

Eurosurveillance Pub Date : 2024-10-01 DOI: 10.2807/1560-7917.ES.2024.29.44.2400084

Kyla Serres, Diana Erazo, Garance Despréaux, María F Vincenti-González, Wim Van Bortel, Elena Arsevska, Simon Dellicour

{"title":"Integrating indicator-based and event-based surveillance data for risk mapping of West Nile virus, Europe, 2006 to 2021.","authors":"Kyla Serres, Diana Erazo, Garance Despréaux, María F Vincenti-González, Wim Van Bortel, Elena Arsevska, Simon Dellicour","doi":"10.2807/1560-7917.ES.2024.29.44.2400084","DOIUrl":"10.2807/1560-7917.ES.2024.29.44.2400084","url":null,"abstract":"BackgroundWest Nile virus (WNV) has an enzootic cycle between birds and mosquitoes, humans being incidental dead-end hosts. Circulation of WNV is an increasing public health threat in Europe. While detection of WNV is notifiable in humans and animals in the European Union, surveillance based on human case numbers presents some limitations, including reporting delays.AimWe aimed to perform risk mapping of WNV circulation leading to human infections in Europe by integrating two types of surveillance systems: indicator-based and event-based surveillance.MethodsFor indicator-based surveillance, we used data on human case numbers reported to the European Centre for Disease Prevention and Control (ECDC), and for event-based data, we retrieved information from news articles collected through an automated biosurveillance platform. In addition to these data sources, we also used environmental data to train ecological niche models to map the risk of local WNV circulation leading to human infections.ResultsThe ecological niche models based on both types of surveillance data highlighted new areas potentially at risk of WNV infection in humans, particularly in Spain, Italy, France and Greece.ConclusionAlthough event-based surveillance data do not constitute confirmed occurrence records, integrating both indicator-based and event-based surveillance data proved useful. These results underscore the potential for a more proactive and comprehensive strategy in managing the threat of WNV in Europe by combining indicator- and event-based and environmental data for effective surveillance and public health response.","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"29 44","pages":""},"PeriodicalIF":9.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11528904/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142557487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Monkeypox Clade Ib virus introduction into Burundi: first findings, July to mid-August 2024. 将猴痘 Ib 支系病毒引入布隆迪：2024 年 7 月至 8 月中旬的首次发现。

IF 9.9 2区医学

Eurosurveillance Pub Date : 2024-10-01 DOI: 10.2807/1560-7917.ES.2024.29.42.2400666

Néhémie Nzoyikorera, Cassien Nduwimana, Leonard Schuele, David F Nieuwenhuijse, Marion Koopmans, Saria Otani, Frank M Aarestrup, Théogène Ihorimbere, Denis Niyomwungere, Armstrong Ndihokubwayo, Idrissa Diawara, Alexis Niyomwungere, Dionis Nizigiyimana, Marie Noelle Uwineza, Bas B Oude Munnink, Joseph Nyandwi

引用次数: 0